National Institute of Environmental Health Sciences Start Printed Page 26758(NIEHS), National Institutes of Health (NIH).
Meeting announcement and request for comments.
Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of SACATM on June 17-18, 2010, at the U.S. Environmental Protection Agency, 109 T.W. Alexander Drive, Research Triangle Park, NC 27711. The meeting is open to the public with attendance limited only by the space available. The meeting will be videocast through a link at (http://www.niehs.nih.gov/news/video/live). SACATM advises the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM), the NTP Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM), and the Director of the NIEHS and NTP regarding statutorily mandated duties of ICCVAM and activities of NICEATM.
The SACATM meeting will be held on June 17 and 18, 2010. The meeting is scheduled from 8:30 a.m. Eastern Daylight Time to 5 p.m. on June 17 and 8:30 a.m. until adjournment on June 18, 2010. All individuals who plan to attend are encouraged to register online at the NTP Web site (http://ntp.niehs.nih.gov/go/32822) by June 10, 2010. In order to facilitate planning, persons wishing to make an oral presentation are asked to notify Dr. Lori White, NTP Designated Federal Officer, via online registration, phone, or e-mail by June 10, 2010 (see ADDRESSES below). Written comments should also be received by June 10, 2010, to enable review by SACATM and NIEHS/NTP staff before the meeting.
The SACATM meeting will be held at the U.S. Environmental Protection Agency, 109 T.W. Alexander Drive, Research Triangle Park, NC 27711. Public comments and other correspondence should be directed to Dr. Lori White (NTP Office of Liaison, Policy and Review, NIEHS, P.O. Box 12233, MD K2-03, Research Triangle Park, NC 27709; telephone: 919-541-9834 or e-mail: firstname.lastname@example.org). Courier address: NIEHS, 530 Davis Drive, Room 2136, Morrisville, NC 27560. Persons needing interpreting services in order to attend should contact 301-402-8180 (voice) or 301-435-1908 (TTY). Requests should be made at least 7 days in advance of the meeting.End Preamble Start Supplemental Information
Preliminary Agenda Topics and Availability of Meeting Materials
Preliminary agenda topics include:
- NICEATM-ICCVAM Update.
- Regulatory Acceptance of ICCVAM-Recommended Alternative Test Methods.
- Assessment of Acute and Chronic Pain in Animals.
- Federal Agency Research, Development, Translation, and Validation Activities Relevant to the NICEATM-ICCVAM Five-Year Plan.
- Current Issues in the Validation of Alternative Methods for Assessing Chemically Induced Eye Injuries.
- Alternative Methods for Vaccine Potency Testing.
- Update from the European Centre for the Validation of Alternative Methods.
- Update from Health Canada.
- Update from the Korean Center for the Validation of Alternative Methods.
A copy of the preliminary agenda, committee roster, and additional information, when available, will be posted on the NTP Web site (http://ntp.niehs.nih.gov/go/32822) or available upon request (see ADDRESSES above). Following the SACATM meeting, summary minutes will be prepared and available on the NTP Web site or upon request.
Request for Comments
Both written and oral public input on the agenda topics is invited. Written comments received in response to this notice will be posted on the NTP Web site. Persons submitting written comments should include their name, affiliation (if applicable), and sponsoring organization (if any) with the document. Time is allotted during the meeting for presentation of oral comments and each organization is allowed one time slot per public comment period. At least 7 minutes will be allotted for each speaker, and if time permits, may be extended up to 10 minutes at the discretion of the chair. Registration for oral comments will also be available on-site, although time allowed for presentation by on-site registrants may be less than for pre-registered speakers and will be determined by the number of persons who register at the meeting. In addition to in-person oral comments at the meeting, public comments can be presented by teleconference line. There will be 50 lines for this call; availability will be on a first-come, first-served basis. The available lines will be open from 8 a.m. until 5 p.m. on June 17 and 8:30 a.m. to adjournment on June 18, although public comments will be received only during the formal public comment periods, which will be indicated on the preliminary agenda. The access number for the teleconference line will be provided to registrants by e-mail prior to the meeting.
Persons registering to make oral comments are asked to do so through the online registration form (http://ntp.niehs.nih.gov/go/32822) and to send a copy of their statement to Dr. White (see ADDRESSES above) by June 10, 2010, to enable review by SACATM, NICEATM-ICCVAM, and NIEHS/NTP staff prior to the meeting. Written statements can supplement and may expand the oral presentation. If registering on-site and reading from written text, please bring 40 copies of the statement for distribution and to supplement the record.
Background Information on ICCVAM, NICEATM, and SACATM
ICCVAM is an interagency committee composed of representatives from 15 Federal regulatory and research agencies that use, generate, or disseminate toxicological information. ICCVAM conducts technical evaluations of new, revised, and alternative methods with regulatory applicability and promotes the development, scientific validation, regulatory acceptance, implementation, and national and international harmonization of new, revised, and alternative toxicological test methods that more accurately assess the safety and hazards of chemicals and products and that refine, reduce, and replace animal use. The ICCVAM Authorization Act of 2000 [42 U.S.C. 285 l-3] established ICCVAM as a permanent interagency committee of the NIEHS under NICEATM. NICEATM administers ICCVAM and provides scientific and operational support for ICCVAM-related activities. NICEATM and ICCVAM work collaboratively to evaluate new and improved test methods applicable to the needs of U.S. Federal agencies. Additional information about ICCVAM and NICEATM, guidelines for nomination of test methods for validation studies, and guidelines for submission of test methods for ICCVAM evaluation are available at: http://iccvam.niehs.nih.gov.
SACATM was established in response to the ICCVAM Authorization Act [Section 285 l-3(d)] and is composed of scientists from the public and private sectors. SACATM advises ICCVAM, NICEATM, and the Director of the NIEHS and NTP regarding statutorily mandated duties of ICCVAM and activities of NICEATM. SACATM Start Printed Page 26759provides advice on priorities and activities related to the development, validation, scientific review, regulatory acceptance, implementation, and national and international harmonization of new, revised, and alternative toxicological test methods. Additional information about SACATM, including the charter, roster, and records of past meetings, can be found at http://ntp.niehs.nih.gov/go/167.Start Signature
Dated: May 4, 2010.
John R. Bucher,
Associate Director, National Toxicology Program.
[FR Doc. 2010-11318 Filed 5-11-10; 8:45 am]
BILLING CODE 4140-01-P